亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

隨州市紅旗化工有限公司  

醫藥原料醫藥中間體原料藥

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:閆先生
  • 電話:0722-3257386
  • 傳真:0722-3257381
  • QQ:1374834438
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 西曲溴胺 CAS號: 8044-71-1
西曲溴胺 CAS號: 8044-71-1
單價 面議對比
詢價 暫無
發貨 湖北隨州市付款后3天內
型號 8044-71-1
過期 長期有效
更新 2020-06-18 10:08
 
詳細信息

西曲溴胺
CAS號: 8044-71-1
中文同義詞: 十四烷基三甲基溴化胺;西曲溴胺;溴烷銨;西曲溴銨40%溶液
英文名稱: Cetrimide
英文同義詞: N-TETRADECYL-N,N,N-TRIMETHYLAMMONIUM BROMIDE;(N-TETRADECYL)TRIMETHYLAMMONIUM BROMIDE;TRIMETHYLMYRISTYLAMMONIUM BROMIDE;TRIMETHYL-TETRADECYLAMMONIUM BROMIDE;TTAB;cetavlon;cetraol;lissolaminev
分子式: C17H38BrN
分子量: 336.39
EINECS號: 214-291-9
含量: ≥99%
標準:企業標準
性狀 :白色粉末或結晶體
用途: 本產品可作催化劑、乳化劑、殺菌劑、消毒劑、抗靜電劑等使用。
包裝: 25kg/紙板桶

©2025 隨州市紅旗化工有限公司 版權所有   技術支持:化工網   訪問量:31400  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |